A new variation of the fake recruiter campaign from North Korean threat actors is targeting JavaScript and Python developers ...

This week’s cyber recap covers AI risks, supply-chain attacks, major breaches, DDoS spikes, and critical vulnerabilities security teams must track.

CrashFix crashes browsers to coerce users into executing commands that deploy a Python RAT, abusing finger.exe and portable Python to evade detection and persist on high‑value systems.

Active React2Shell exploitation uses malicious NGINX configurations to hijack web traffic, targeting Baota panels, Asian TLDs ...

Organizations have a wealth of unstructured data that most AI models can’t yet read. Preparing and contextualizing this data is essential for moving from AI experiments to measurable results. In ...

Next week is jampacked with potential market movers, including midweek inflation data and a host of other economic indicators. Several Federal Reserve speeches are also on the docket, as well as the ...

Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to ...

U.S. jobs data for December and ISM data on U.S. manufacturing and services-sector activity will be the key focus in the coming week as investors gauge the health of the economy and the likely timing ...

Google is ending its dark web report, with scans stopping Jan. 15, 2026. Google says it is shifting to tools with clearer, actionable guidance. Other dark web monitoring tools and scanners are still ...

Google’s dark web reports gave users important info, but not enough “helpful next steps.” Google’s dark web reports gave users important info, but not enough “helpful next steps.” is a news writer ...

Google began offering “dark web reports” a while back, but the company has just announced the feature will be going away very soon. In an email to users of the service, Google says it will stop ...

In my last note on Altimmune, Inc. (ALT) shared in late August, I made the bull case for its stock. I discussed the Gaithersburg, Maryland based biotech's lead and only drug candidate, pemvidutide, ...